Serum levels of CEA, CA19-9, CA-125, cancer-related antigen 72-4, and mucin-like carcinoma-associated antigen, and fluid viscosity are expected to be significantly lower in patients with LECs than in those with mucinous neoplasms [9,12,13]. The gene discussed is CEACAM5; the disease is mucinous neoplasm.